Therapeutic Asset Ratings

748 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Dpx-Survivac Fallopian Tube Cancer	University Health Network, Toronto	P2	B (56)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Acute Lymphoblastic Leukemia	City of Hope Medical Center	P2	B (56)
Tetanus Toxoid Glioblastoma	Charlotte Lemech	P2	B (56)
Aadvac1 Alzheimer Disease	Paul S. Aisen	P2	CCC (55)
MODERNA COVID-19 VACCINE RNA AL Amyloidosis	Barbara Ann Karmanos Cancer Institute	P2	CCC (55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Lymphoblastic Lymphoma	City of Hope Medical Center	P2	CCC (55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Myelodysplastic Syndrome	City of Hope Medical Center	P2	CCC (55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Myelofibrosis	City of Hope Medical Center	P2	CCC (55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Non-Hodgkin Lymphoma	City of Hope Medical Center	P2	CCC (55)
Survaxm Glioblastoma	Children's Oncology Group	P2	CCC (55)
DIPHTHERIA TOXOID Multiple Sclerosis	Celgene	P3	CCC (54)
Moderna Bivalent Mrna Vaccine Non-Hodgkin Lymphoma	Monash University	P3	CCC (54)
Pfizer Bivalent Covid-19 Vaccine Non-Hodgkin Lymphoma	Monash University	P3	CCC (54)
Recombinant Covid-19 Vaccine For Inhalation COVID-19	Seventh Medical Center of PLA General Hospital	P3	CCC (54)
Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine Multiple Sclerosis	Celgene	P3	CCC (54)
Bacillus Calmette-Guerin Cognitive Disorder	Steven E Arnold, MD	P2	CCC (54)
Ptvg-Ar Prostate Cancer	University of Wisconsin, Madison	P2	CCC (54)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine Ovarian Carcinoma	University of Washington	P2	CCC (54)
9-valent human papillomavirus recombinant vaccine Human Papilloma Virus Infection	University Health Network, Toronto	P2	CCC (53)
Aadvac1 Progressive Supranuclear Palsy	Adam Boxer	P2	CCC (53)
ad5 cea vaccine Colorectal Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
ad5 cea vaccine Lynch Syndrome	National Cancer Institute (NCI)	P2	CCC (53)
Adenovirus 5 Cea/Muc1/Brachyury Vaccine Tri-Ad5 Colorectal Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Adenovirus 5 Cea/Muc1/Brachyury Vaccine Tri-Ad5 Lynch Syndrome	National Cancer Institute (NCI)	P2	CCC (53)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre Esophageal Adenocarcinoma	Thomas Jefferson University	P2	CCC (53)

Showing 126 to 150 of 748 assets

PreviousPage 6 of 30Next